Home-based Intervention with Semaglutide Treatment of Neuroleptic-Related Prediabetes (HISTORI): protocol describing a prospective, randomised, placebo controlled and double-blinded multicentre trial
Introduction Subjects with schizophrenia have a 2–3 fold higher mortality rate than the general population and a reduced life expectancy of 10–20 years. Approximately one-third of this excess mortality has been attributed to obesity-related type 2 diabetes (T2D) and to cardiovascular disease. Glucag...
Saved in:
| Main Authors: | Peter Haulund Gæde, Jan Frystyk, Niels Bilenberg, Ashok Ainkaran Ganeshalingam, Nicolai Gundtoft Uhrenholt, Sidse Arnfred |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-03-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/14/3/e077173.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroleptic malignant syndrome
by: Mariana Moscovich, et al.
Published: (2011-10-01) -
Complications of neuroleptic hyperprolactinaemia
by: G. E. Mazo, et al.
Published: (2018-11-01) -
Neuroleptic hyperprolactinemia medicamentous correction
by: L. N. Gorobets, et al.
Published: (2018-07-01) -
Neuroleptic Malignant Syndrome and Methylphenidate
by: J Gordon Millichap
Published: (1998-12-01) -
MORPHOMETRIC ASPECTS OF NEUROLEPTIC CARDIOMYOPATHY MORPHOGENESIS
by: V. P. Volkov
Published: (2012-06-01)